204 related articles for article (PubMed ID: 30078585)
1. Pathological, immunological and parasitological study of sheep vaccinated with the recombinant protein 14-3-3z and experimentally infected with Fasciola hepatica.
Pérez-Caballero R; Siles-Lucas M; González-Miguel J; Martínez-Moreno FJ; Escamilla A; Pérez J; Martínez-Moreno A; Buffoni L
Vet Immunol Immunopathol; 2018 Aug; 202():115-121. PubMed ID: 30078585
[TBL] [Abstract][Full Text] [Related]
2. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D
Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976
[TBL] [Abstract][Full Text] [Related]
3. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep.
Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G
Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with cathepsin L phage-exposed mimotopes, single or in combination, reduce size, fluke burden, egg production and viability in sheep experimentally infected with Fasciola hepatica.
Villa-Mancera A; Alcalá-Canto Y; Reynoso-Palomar A; Olmedo-Juárez A; Olivares-Pérez J
Parasitol Int; 2021 Aug; 83():102355. PubMed ID: 33872793
[TBL] [Abstract][Full Text] [Related]
5. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
[TBL] [Abstract][Full Text] [Related]
6. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
[TBL] [Abstract][Full Text] [Related]
7. Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep.
Ortega-Vargas S; Espitia C; Sahagún-Ruiz A; Parada C; Balderas-Loaeza A; Villa-Mancera A; Quiroz-Romero H
Vaccine; 2019 May; 37(24):3234-3240. PubMed ID: 31036453
[TBL] [Abstract][Full Text] [Related]
8. An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3).
Mezo M; González-Warleta M; Carro C; Ubeira FM
J Parasitol; 2004 Aug; 90(4):845-52. PubMed ID: 15357080
[TBL] [Abstract][Full Text] [Related]
9. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
[TBL] [Abstract][Full Text] [Related]
10. Phage display-based vaccine with cathepsin L and excretory-secretory products mimotopes of Fasciola hepatica induces protective cellular and humoral immune responses in sheep.
Villa-Mancera A; Olivares-Pérez J; Olmedo-Juárez A; Reynoso-Palomar A
Vet Parasitol; 2021 Jan; 289():109340. PubMed ID: 33373968
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a multivalent vaccine against Fasciola hepatica infection in sheep.
Zafra R; Buffoni L; Pérez-Caballero R; Molina-Hernández V; Ruiz-Campillo MT; Pérez J; Martínez-Moreno Á; Martínez Moreno FJ
Vet Res; 2021 Jan; 52(1):13. PubMed ID: 33509286
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of sheep against Fasciola hepatica with homologous fatty acid binding proteins.
Ramajo V; Oleaga A; Casanueva P; Hillyer GV; Muro A
Vet Parasitol; 2001 May; 97(1):35-46. PubMed ID: 11337125
[TBL] [Abstract][Full Text] [Related]
13. Immune response of goats immunised with glutathione S-transferase and experimentally challenged with Fasciola hepatica.
Buffoni L; Zafra R; Pérez-Ecija A; Martínez-Moreno FJ; Martínez-Galisteo E; Moreno T; Pérez J; Martínez-Moreno A
Parasitol Int; 2010 Jun; 59(2):147-53. PubMed ID: 20035898
[TBL] [Abstract][Full Text] [Related]
14. Attempted immunisation of sheep against Fasciola hepatica using gamma-irradiated metacercariae.
Creaney J; Spithill TW; Thompson CM; Wilson LR; Sandeman RM; Parsons JC
Int J Parasitol; 1995 Jul; 25(7):853-6. PubMed ID: 7558572
[TBL] [Abstract][Full Text] [Related]
15. Fasciola hepatica antioxidant and protease-inhibitor cocktail recombinant vaccines administered five times elicit potent and sustained immune responses in sheep but do not confer protection.
Cwiklinski K; McEvoy A; López Corrales J; Jewhurst H; Calvani NED; De Marco Verissimo C; Dorey AL; Keane OM; Dalton JP; Lalor R
Vet Parasitol; 2023 Nov; 323():110049. PubMed ID: 37826973
[TBL] [Abstract][Full Text] [Related]
16. Pathological and parasitological protection in goats immunised with recombinant cathepsin L1 and challenged with Fasciola hepatica.
Pérez-Ecija RA; Mendes RE; Zafra R; Buffonni L; Martínez-Moreno A; Pérez J
Vet J; 2010 Sep; 185(3):351-3. PubMed ID: 19665401
[TBL] [Abstract][Full Text] [Related]
17. Protection and antibody isotype responses against Fasciola hepatica with specific antibody to pIII-displayed peptide mimotopes of cathepsin L1 in sheep.
Villa-Mancera A; Méndez-Mendoza M
Vet J; 2012 Oct; 194(1):108-12. PubMed ID: 22513301
[TBL] [Abstract][Full Text] [Related]
18. Humoral immune response in calves to single-dose, trickle and challenge infections with Fasciola hepatica.
Bossaert K; Farnir F; Leclipteux T; Protz M; Lonneux JF; Losson B
Vet Parasitol; 2000 Jan; 87(2-3):103-23. PubMed ID: 10622602
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep.
Sexton JL; Milner AR; Panaccio M; Waddington J; Wijffels G; Chandler D; Thompson C; Wilson L; Spithill TW; Mitchell GF
J Immunol; 1990 Dec; 145(11):3905-10. PubMed ID: 1978849
[TBL] [Abstract][Full Text] [Related]
20. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
